All Substitutes
Loading...
Disclaimer
Did you find this information helpful?



Peglec Powder 137.15gm
Prescription Required
Salt Composition : Electrolytes For Oral Solution,polyethylene Glycol 3350
Manufacturer : TABLETS INDIA LIMITED
Origin of Medicine : India
1 Sachet(s)
Introduction to Peglec Powder 137.15gm
Peglec Powder 137.15gm is a medication that combines polyethylene glycol 3350 and electrolytes. It cleanses the colon (bowel) and is prescribed for the treatment of constipation, which is characterized by infrequent bowel movements. Peglec powder for colonoscopy is widely used to prepare the bowel before procedures like colonoscopy and colorectal surgery.
Do not consume Peglec Powder if you are allergic to electrolytes for oral solution, polyethylene glycol, or any of the ingredients in the medication. Before starting the treatment, inform your doctor if you have intestinal perforation or obstruction, severe inflammatory conditions of the intestinal tract like Crohn's disease and ulcerative colitis, and toxic megacolon. If you are on a salt-controlled diet, notify your doctor. Also, report any history of heart problems, electrolyte imbalances, kidney disease, seizures, gastroesophageal reflux disease (GERD), trouble swallowing, G6PD deficiency, or drug/alcohol addiction. Additionally, inform your doctor if you are pregnant, breastfeeding, or have phenylketonuria (increased phenylalanine level in the blood).
If patients experience symptoms of fluid or electrolyte shifts (edema, shortness of breath, increasing fatigue, dehydration, cardiac failure), Peglec Powder 137.15gm should be stopped immediately. Electrolyte levels should be measured and treated as necessary. Before starting the medicine, patients with symptoms of bowel obstruction (nausea, vomiting, abdominal pain/distention) should be evaluated, and those with constipation should undergo a thorough examination to identify underlying causes. Always check the Peglec powder price before purchasing it, whether from an online store or a retail pharmacy.
Uses of Peglec Powder 137.15gm
Peglec powder uses include:
- Treating constipation
- Bowel cleansing before medical procedures like colonoscopy and colorectal surgery
Peglec powder benefits primarily revolve around its ability to clean the colon effectively, making it easier for doctors to perform accurate diagnostic procedures.
Therapeutic Effects of Peglec Powder 137.15gm
Peglec Powder 137.15gm causes water retention in the stool, loosens the stools, and facilitates bowel movements. It helps you to have comfortable bowel movements even if you have been constipated for a long time. The composition of Peglec powder includes polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride, making it highly effective for cleansing the bowel.
Interaction of Peglec Powder 137.15gm with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Peglec Powder 137.15gm and cause undesirable side effects. Be cautious when taking medications that may affect electrolyte balance or worsen dehydration.
More Information about Peglec Powder 137.15gm
- Keep Peglec sachets out of sight and reach of pets and children.
- Do not freeze the medicine.
- Do not store above 30°C.
- Always check the expiry date before consuming it.
- The Peglec sachet price may vary depending on the pharmacy and location, so compare prices before purchasing.
How to consume Peglec Powder 137.15gm
Take Peglec Powder 137.15gm as your physician advises. It is important to wait at least one hour after consuming solid food before drinking a polyethylene glycol electrolyte solution. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
To prepare the sachet Peglec powder, mix the contents of the sachet with the recommended amount of water and stir well until dissolved. Peglec powder how to use guidelines should be followed strictly to achieve the desired results.
Safety Advices for Peglec Powder 137.15gm
Pregnancy
It is unknown whether Peglec Powder 137.15gm is harmful to the unborn baby. Notify your healthcare professional if you are pregnant, planning to have a baby, or think you may be pregnant.
Breast Feeding
Peglec Powder 137.15gm should be cautiously taken during breastfeeding. Before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information.
Lungs
It is unknown whether Peglec Powder 137.15gm is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
Liver
It is unknown whether Peglec Powder 137.15gm is safe for patients with liver problems. Inform your doctor if you have any liver disease before starting the treatment.
Alcohol
Do not consume alcohol while taking Peglec Powder 137.15gm. Please speak with your physician.
Driving
It is unknown whether Peglec Powder 137.15gm alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
Side Effects of Peglec Powder 137.15gm
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Common
- Bloating
- Stomach pain, discomfort
- Diarrhea
- Dizziness
- Less or no urination
- Seizure
- Signs of electrolyte imbalance (dry mouth, confusion, constipation, muscle pain or weakness)
Word of Advice
Before starting the treatment, inform your doctor about all underlying medical conditions. Do not stop the medicine until your doctor advises you to. Do not double-dose the medicine to make up for a forgotten dose. Notify your doctor if you experience any serious side effects. For those considering Peglec powder for constipation, ensure you follow your doctor's instructions for optimal results.
FAQs
Q 1. Can children use Peglec Powder 137.15gm?
It is unknown whether the medicine is safe to use in children. Consult a healthcare professional for more details about using Peglec Powder 137.15gm in children. The suitability of any medication depends on factors such as age, weight, and specific medical conditions.
Q 2. What are the side effects of Peglec Powder 137.15gm?
Common side effects of Peglec Powder 137.15gm include bloating, stomach pain, discomfort, diarrhea, dizziness, less or no urination, seizure, and signs of electrolyte imbalance (dry mouth, confusion, constipation, muscle pain or weakness). It is crucial to consult your doctor for any concerns or persistent side effects.
Q 3. Can Peglec Powder 137.15gm be taken during pregnancy or while breastfeeding?
Information regarding using Peglec Powder 137.15gm during pregnancy and breastfeeding is unknown. So, getting healthcare professionals' advice before consuming the medicine is recommended. The potential benefits and risks of the medicine should be carefully assessed.
Q 4. What should I do if I miss a dose of Peglec Powder 137.15gm?
If you miss a dose, take it as soon as possible. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose of the Peglec Powder 137.15gm.
Fact Box of Peglec Powder 137.15gm
Molecule name: Electrolytes for oral solution + Polyethylene glycol
| Therapeutic class: Gastrointestinal disorder |
Pharmacological class: Electrolytes | Indications: 1. Treat constipation 2. Bowel cleansing before medical procedures like colonoscopy and colorectal surgery |
References
- Norgine Limited, Electronic medicines compendium (emc), [Revised on March 2021] [ Accessed on 04th July 2023], https://www.medicines.org.uk/emc/files/pil.1025.pdf
- Ciplamed; [Revised on July 2018] [Accessed on 04th July 2023]; https://www.ciplamed.com/content/cipeg-powder
- Drugs.com, [Accessed on 04th July 2023]; https://www.drugs.com/mtm/polyethylene-glycol-electrolyte-solution.html
- Atsushi Nakajima et al; Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension; Journal of Gastroenterology; [Published on Sept 2019]; [Accessed on 04th July 2023]; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6698298/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.